The commentary responds to a short communication by Hamm and colleagues describing computed tomography-guided percutaneous marking of lung nodules using two well-established agents: patent blue V, a visible dye, and indocyanine green, a fluorescent tracer that glows under near-infrared light. The German team also explored indocyanine green-soaked coils, small metallic spirals drenched in the fluorescent dye before deployment. In their reported series, all patients underwent complete resection without conversion to open surgery, a result the commentary authors describe as underscoring the technical reliability of the approach. What makes the technique attractive, they note, is its accessibility and workflow flexibility: the marking is performed percutaneously in the radiology suite, avoiding rigid transpleural devices that must stay in place until resection, and eliminating the need for intraoperative fluoroscopy altogether.

That last point matters more than it might first appear. Robotic-assisted thoracic surgery has transformed minimally invasive lung resection, offering articulated instruments, high-definition three-dimensional vision, and steady precision within a confined chest cavity. But robotic operating environments are notoriously unfriendly to techniques that require a fluoroscope to be wheeled in mid-operation. Hybrid operating rooms equipped with integrated imaging remain scarce and expensive, particularly outside major academic centres. A localisation strategy that relies on preoperative computed tomography guidance and then hands off to near-infrared fluorescence, which integrates seamlessly into robotic camera platforms, preserves operative ergonomics and could allow hospitals without hybrid theatres to offer minimally invasive sublobar resection to their patients. In this sense, the commentary frames computed tomography-guided fluorescence as a platform technology reinforcing the expanding role of interventional radiology in precision thoracic oncology.

To understand where the field is heading, the authors propose a generational framework for pulmonary localisation strategies. The first generation was hook-wire localisation, in which a thin wire with a hooked tip is placed into or adjacent to the nodule under imaging guidance. Wires are effective but carry well-known drawbacks: they can displace, they puncture the pleura and can cause pneumothorax, and the rigid external component must be managed carefully until the surgeon removes it. The second generation was percutaneous dye injection, simple and cheap, but vulnerable to two failure modes: dyes diffuse through the soft lung parenchyma and they fade over time, so the target zone a surgeon sees may no longer correspond to where the dye was originally placed. The third generation introduced coil-assisted fluorescence, in which a metallic coil provides mechanical containment for the fluorescent dye, improving durability and visibility.

It is the fourth generation, still emerging, that excites the commentary’s authors most: stabilised fluorescent matrices designed to optimise spatial fidelity. The central insight is that diffusion control is not a minor technical detail but the very heart of localisation accuracy. When liquid dye is injected into lung tissue, it spreads laterally through the interstitium, creating a fluorescent zone that grows and blurs over time. Visibility without spatial fidelity, the authors warn, risks misleading surgical guidance. In a lobectomy, where the entire lobe is removed, a few millimetres of dye drift are inconsequential. But in a sublobar resection, a segmentectomy or wedge resection intended to preserve as much healthy lung as possible, margin geometry is everything. If the fluorescent cloud has migrated, the surgeon may resect around the wrong centre, compromising the distance between the tumour edge and the cut margin.

The stakes of margin integrity have been raised sharply by randomised evidence. The Japanese JCOG0802/WJOG4607L trial, a multicentre phase 3 study published in The Lancet in 2022, demonstrated that segmentectomy is non-inferior to lobectomy for small peripheral non-small-cell lung cancer, validating lung-preserving surgery for selected early-stage patients. That victory for tissue-sparing oncology, however, makes the localisation problem more acute rather than less. When the goal shifts from removing an entire lobe to carving out a precise wedge around a ten-millimetre lesion, the surgeon depends absolutely on the fidelity of whatever marker was placed the day before. Margin distance and local recurrence become the decisive metrics, and any localisation technique that cannot guarantee spatial accuracy becomes the weak link in an otherwise elegant chain.

This is why the commentary insists that future localisation research be framed by oncologic endpoints rather than technical success alone. Viana and Nunes call for systematic reporting of lesion depth, minimal margin distance, and longitudinal local recurrence in every study of nodule marking. Complete resection rates, while reassuring, are a blunt instrument; a resection can be complete yet carry a margin so narrow that recurrence risk rises. They also urge multicentre prospective validation within robotic workflows, recognising that single-centre feasibility studies, however encouraging, cannot establish whether a technique performs consistently across different operators, scanner platforms, and patient anatomies. Whether molecular stabilisation of fluorescent dyes translates into superior oncologic precision, they acknowledge, requires exactly this kind of prospective evaluation, but the conceptual evolution is notable.

The stabilised matrix concept represents a genuinely biochemical approach to a problem that previous generations attacked mechanically. Rather than containing dye with a coil or accepting its diffusion as inevitable, these formulations modulate dye distribution at the injection site itself, reducing lateral spread and potentially improving margin predictability. The commentary’s authors have direct experience in this territory: they previously published a technical note on computed tomography-guided dual-fluorescent marking for robotic sublobar resection covering 84 consecutive cases, work cited in their commentary as part of the field’s progression. Their argument is that these four generations, hook-wires, dye injections, coil-assisted fluorescence, and stabilised matrices, should be understood not as competitors but as iterative refinements, each responding to a clearly identified limitation of its predecessor.

For readers wondering why this seemingly niche surgical debate deserves broader attention, the answer lies in the convergence of three trends that are reshaping cancer care worldwide. Screening programmes are expanding, which means more small nodules will be found and more of them will be operated on. Robotic platforms are proliferating, which means more of those operations will be performed with instruments that cannot palpate a lesion hidden in deflated lung tissue. And lung-preserving resection is gaining evidence-based legitimacy, which means the precision demands on localisation will only intensify. The commentary’s closing line captures the moment succinctly: if feasibility has defined the past decade of computed tomography-guided localisation, precision will define the next. What began as a practical question of how to mark a spot in the lung is maturing into a rigorous discipline of spatial oncology, where the biochemistry of a dye, the geometry of a surgical margin, and the long-term risk of cancer recurrence are inseparably linked.

There are, of course, caveats that the commentary itself makes explicit. The heterogeneity of marking techniques currently in use, spanning simple dye injection and coil-assisted fluorescence, reflects an important developmental phase but may limit standardisation, making head-to-head comparisons difficult. The stabilised fluorescent matrices remain conceptually promising rather than prospectively proven, and their advantage over coil containment must be demonstrated in controlled studies. Nor does the commentary claim that any single technique is universally superior; instead, it offers a roadmap for how the field should evaluate its options. For a specialty in which a few millimetres of tissue can determine whether a patient keeps half a lung or loses a whole one, that shift in standards, from visible to verifiable, from feasible to faithful, may prove to be the most consequential development in thoracic surgical oncology this decade.

Subject of Research: Computed tomography-guided fluorescent localisation of small pulmonary nodules for robotic thoracic surgery

Article Title: Evolving generations of computed tomography-guided lung nodule localisation toward stabilised fluorescent precision in robotic thoracic oncology

Article References: Viana, P. C. C., & Nunes, T. F. (2026). Evolving generations of computed tomography-guided lung nodule localisation toward stabilised fluorescent precision in robotic thoracic oncology. CVIR Oncology, 2(1), Article 31. https://doi.org/10.1007/s44343-026-00036-4

Image Credits: AI Generated

DOI: 10.1007/s44343-026-00036-4

Keywords: lung nodule localisation, computed tomography guidance, indocyanine green, patent blue V, fluorescence imaging, robotic thoracic surgery, sublobar resection, segmentectomy, surgical margins, interventional radiology, precision oncology, stabilised fluorescent matrices

Congenital lung malformations encompass a spectrum of structural abnormalities, including congenital pulmonary airway malformations, in which cyst-like maldeveloped airway tissue replaces normal lung, and pulmonary sequestration, in which a piece of lung tissue lacks a normal connection to the airway and instead receives its blood supply from the systemic circulation. When these lesions occupy the posterior and lateral basal segments of the lower lung lobe, the segments labeled S9 and S10 in the standard anatomical numbering system, surgeons have traditionally faced a choice between removing the entire lobe through a lobectomy or performing a segmentectomy that isolates and removes only the affected segments. Each option carries trade-offs that matter enormously for a growing child.

Lobectomy is technically straightforward and reliably removes the malformation, which is why it has long been the default operation. But a child’s lungs continue to develop throughout childhood, and every gram of healthy parenchyma removed represents tissue that can never contribute to gas exchange. Segmentectomy, by contrast, demands meticulous dissection of the segmental blood vessels, airways, and the invisible planes between adjacent lung segments, but it preserves the superior segment, known as S6, and its vital connection to the remaining basal lung tissue. The team behind the new study, led by surgeons at the Children’s Hospital Affiliated to Shandong University and Jinan Children’s Hospital, set out to determine whether their arch-shaped modification of segmentectomy could make this lung-sparing option safer and more predictable.

The retrospective analysis reviewed the records of 77 children with congenital lung malformations who underwent thoracoscopic surgery between January 2019 and June 2023. The patients were divided into three groups according to the operation they received: 22 children underwent thoracoscopic lobectomy, 33 underwent conventional thoracoscopic S9-10 segmentectomy, and 22 underwent the new “Arch” thoracoscopic S9-10 segmentectomy. The researchers compared perioperative outcomes, postoperative findings, and radiological follow-up across the groups, and they applied the Bonferroni correction to pairwise comparisons, a statistical adjustment designed to reduce the risk of false-positive findings when multiple comparisons are made simultaneously.

The defining feature of the Arch technique lies in how the surgeon shapes the cut across the lung parenchyma. In a conventional segmentectomy, the division of the S9-10 segments can leave a broad, flat raw surface on the remaining lung, and the interface between the resected area and the preserved superior segment can be technically awkward to manage. The Arch approach instead creates an arch-like, curved resection line that follows the natural anatomical boundary between the basal segments and the superior segment. This curved geometry is intended to preserve the connection between S6 and the remaining basal parenchyma more faithfully, maintain the natural contour of the lower lobe, and reduce tension on the staple or suture lines that seal the lung after the diseased tissue is removed.

Every one of the 77 procedures in the study was completed thoracoscopically, meaning the surgeons operated through small incisions using a camera and long instruments rather than opening the chest. There were no conversions to open thoracotomy, no reoperations, no severe complications, and no residual lesion left behind in any patient. That clean safety record across all three surgical approaches is itself a notable finding, because segmentectomy in children is widely regarded as more technically demanding than lobectomy, and the study demonstrates that in experienced hands both conventional and arch-shaped segmentectomy can be completed entirely through keyhole surgery.

When the researchers examined the details of recovery, some expected patterns emerged. Lobectomy was associated with shorter operative time, shorter chest tube duration, and a shorter postoperative hospital stay than either of the segmentectomy procedures, which is consistent with the simpler nature of removing an entire lobe at once rather than dissecting individual segments. Comparing the two segmentectomy techniques directly, the Arch group showed lower mean blood loss than the conventional group, although the authors were careful to note that the absolute difference was small. The difference in operative time between the two segmentectomy groups did not remain statistically significant after adjustment for multiple comparisons, a reminder that apparent advantages seen in raw numbers can dissolve under rigorous statistical scrutiny.

Complications in the series were few and mild. Postoperative air leak, a common and usually self-limiting event in lung surgery in which air escapes from the cut lung surface into the chest drain, occurred in exactly one patient in each of the two segmentectomy groups, and both leaks resolved with drainage alone. In the Arch group, two patients developed a loculated postoperative air collection, meaning a pocket of air became walled off within the chest cavity, but these collections resolved spontaneously within three months without any surgical intervention. No major complications were observed in the Arch group, and the overall perioperative event profile was similar across all three groups in this series.

The authors are explicit that the study’s conclusions must be interpreted with appropriate caution. As a retrospective review, the analysis depends on how patients were selected for each operation in the first place, and the groups were not randomized. The small differences in perioperative outcomes between the techniques should not be overread, particularly given the statistical adjustments and the modest size of the cohorts. What the study does establish, according to its authors, is feasibility: in selected children whose congenital lung malformations are confined to the S9-10 segments, the Arch thoracoscopic segmentectomy can be performed safely, with no major complications observed, and its main potential value lies in preserving the S6-basal segment connection and normal lung parenchyma that a lobectomy would sacrifice.

That preservation may prove to be the technique’s most important legacy. For a child with decades of growth and physical activity ahead, the difference between losing an entire lower lobe and losing only its two most diseased basal segments could translate into meaningfully better lung function, exercise capacity, and quality of life over a lifetime. The research team emphasizes that prospective studies with long-term functional assessment are needed before the Arch technique can be considered a standard of care, and such studies would need to measure not just operative metrics but actual lung growth and function over years of follow-up. Until then, the study stands as an encouraging proof of concept that the geometry of a surgical resection line, shaped like an arch to respect the lung’s natural architecture, may help surgeons remove disease while giving healthy tissue every chance to thrive.

Subject of Research: Arch-shaped thoracoscopic segmentectomy for congenital lung malformations in children

Article Title: Arch-like thoracoscopic posterior and lateral basal segmentectomy for congenital lung malformations in children

Article References: Guo, R., Zhang, S., Zhai, Y., Zhao, H., Cui, R., & Li, J. (2026). Arch-like thoracoscopic posterior and lateral basal segmentectomy for congenital lung malformations in children. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07655-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07655-z

Keywords: congenital lung malformations, thoracoscopy, segmentectomy, pediatric surgery, minimally invasive surgery, lung-preserving surgery, lobectomy, S9-10 segments, pulmonary sequestration, CPAM, thoracic surgery, BMC Pediatrics